SCM Lifescience is a biotechnology company specializing in the development of advanced stem cell therapies. The company focuses on creating personalized medicine solutions by leveraging cutting-edge metabolomics and ultra-performance liquid chromatography quadrupole time-of-flight mass spectrometry. SCM Lifescience primarily serves the healthcare sector, targeting patients with chronic and degenerative diseases. Operating in the global biotechnology market, the company employs a business model centered around research and development, clinical trials, and eventual commercialization of its proprietary stem cell therapies. Revenue is generated through partnerships, licensing agreements, and direct sales of its therapeutic products. The company is committed to innovation and scientific excellence, aiming to improve patient outcomes through personalized and effective treatments.

Keywords: stem cell therapy, personalized medicine, metabolomics, biotechnology, healthcare, chronic diseases, degenerative diseases, clinical trials, R&D, therapeutic products.